Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru embedded insurance API serving 5M+ customers across India and Zambia; YC W21 $6.5M enabling fintechs and e-commerce platforms to integrate insurance at point-of-transaction.
Bimaplan is a Bengaluru, India-based embedded insurance API platform enabling digital companies — fintechs, e-commerce platforms, lending apps, and super-apps — to integrate insurance products at the point of transaction through a single API, providing end-to-end insurance distribution infrastructure from quote through policy issuance and claims for the Indian and African markets. Founded in 2020 and backed by Y Combinator (W21) with $6.5 million raised including a $3.5 million Pre-Series A in October 2023, Bimaplan has served nearly 5 million customers, generated ₹9.36 crore ($1.12 million) in revenue as of March 2024, and has expanded internationally to Zambia with plans for broader Africa and Middle East expansion.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.